BMY241220C43000
- 13.33
- 0.000.00%
Bristol-Myers Squibb Newsroom
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
J.P. Morgan Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Raises Target Price to $70
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Jim Cramer on Bristol-Myers Squibb (BMY): Why Schizophrenia Drug Cobenfy Could Change the Game
Express News | Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
BioArctic Partners With Bristol Myers Squibb In Licensing Deal For PyroGlutamate-Amyloid-Beta Antibody Program
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Is Bristol-Myers Squibb Company (BMY) the Best Cash-Rich Dividend Stock to Invest In Now?
Unusual Options Activity: NVT, IDXX and Others Attract Market Bets, NVT V/OI Ratio Reaches 238.0
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Insitro Receives $25M In Milestone Payments From Bristol Myers Squibb For Achievement Of Discovery Milestones And Selection Of First Novel Genetic Target For ALS
Insitro Receives $25 Million in Milestone Payments From Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Urothelial Cancer Drugs Markets and Competitive Landscape Analysis, 2024-2030, Featuring Profiles of 42 Major Companies, Including AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, and Eli Lilly & Co
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields